NCT01006382

Brief Summary

Anaphylaxis is a severe and potentially life threatening allergic reaction which can affect the airway, breathing and/or circulation. This reaction can be triggered by a number of different allergens but the most common are food, medications, insect venom and latex. Because these reactions occur suddenly and are potentially very serious, the best management lies in the correct use of the prescribed emergency medication. Epinephrine, or adrenaline as it is more commonly known, is the recommended drug for the treatment of anaphylaxis. Injecting the epinephrine into the outer thigh muscle is the preferred route of administration. For health professionals, patients and carers, this rapid administration is facilitated by the manufacture of preloaded syringes and autoinjectors. Despite the availability of these devices, a review of studies shows poor knowledge and skills amongst both health professionals and patients with regards to using autoinjectable epinephrine devices correctly. These studies found that as well as poor knowledge in using the autoinjectors, there was a lack of confidence amongst patients and an unwillingness to carry the device with them at all times. In other disease groups like asthma and diabetes, psychological models which involve asking people how they think about their illness and their related behaviours, have been found to help in the understanding of why some people follow or adhere to health professionals advice and why others do not. Based on these findings, this study will look at two appropriate psychological models and their ability to predict variation in adherence to self-care regimens in adolescents and young adults with food allergy related anaphylaxis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
275

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2010

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 2, 2009

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
Last Updated

June 22, 2011

Status Verified

October 1, 2009

Enrollment Period

1.2 years

First QC Date

October 30, 2009

Last Update Submit

June 21, 2011

Conditions

Outcome Measures

Primary Outcomes (1)

  • Self-reported adherence to self-care regimens of adolescents and young adults with food allergy

    Upon receipt of questionnaire

Study Arms (1)

Adolescents and young adults with food allergy

Adolescents aged 13-21 years with a diagnosis of food allergy

Eligibility Criteria

Age13 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Hospital and community sample

You may qualify if:

  • Aged between 13-21 years
  • Diagnosis of food allergy
  • Prescription of an epinephrine auto-injector

You may not qualify if:

  • If participants are unable to write or understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Brighton & Sussex Medical School

Brighton, East Sussex, BN1 9PH, United Kingdom

Location

Brighton General Hospital

Brighton, East Sussex, BN2 3EW, United Kingdom

Location

Royal Alexandra Children's Hospital

Brighton, East Sussex, BN2 5BE, United Kingdom

Location

St Thomas' Hospital

London, SE1 7EH, United Kingdom

Location

MeSH Terms

Conditions

Food Hypersensitivity

Condition Hierarchy (Ancestors)

Hypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Christina J Jones, BA MSc

    Brighton & Sussex Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 30, 2009

First Posted

November 2, 2009

Study Start

January 1, 2010

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

June 22, 2011

Record last verified: 2009-10

Locations